Yadira Torres MAS/LinkedIn
Sep 15, 2026, 11:55
Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
Yadira Torres MAS, Executive Director at Children’s Hospital Los Angeles, shared CHLA’s post on LinkedIn:
“A new study led by CHLA may help answer a key question for physicians treating children with immune thrombocytopenia (ITP):
Which patients will recover on their own, and which will develop chronic disease?”
Children’s Hospital Los Angeles (CHLA) shared a post on LinkedIn:
“Which children with immune thrombocytopenia (ITP) will recover on their own and which will develop chronic disease?
A multicenter study led by CHLA’s Dr. Taylor Kim validated a prediction model that could help physicians answer that question when a child is first diagnosed.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration